Síndrome de hiperemesis cannabinoide

Torres, F.; Laveglia, Vanessa; Molera, Cristina; Bonet, Mariona

doi:10.1016/j.anpedi.2018.01.002

Cited by 1 publication

(2 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… [6] Other causes of XX OT-DSD include mutations in NR5A1 , aberrant expression of SOX3 , duplication of SOX9 , and mutations in RSPO1 and WNT4 . [ 12 13 ]…”

Section: Discussionmentioning

confidence: 99%

“… [2] In Africa, due to cultural factors, most 46,XX OT-DSDs are reared as males; however, in countries beyond Africa, these individuals tend to be reared as females. [12] Ideally, a multidisciplinary team consisting of specialists in urology, gynecology, endocrinology, psychology, psychiatry, radiology, pathology, genetics, and clinical biochemistry should be mandatory for the assessment and care of such patients. [2] Most importantly, the functional potential of the internal and external genitalia should be determined, [14] as fertility is often impaired in cases of OT-DSD for both males and females.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

46, XX Ovotesticular disorder of sex development (true hermaphroditism) with seminoma

Liu²,

Peng³

et al. 2020

Medicine

View full text Add to dashboard Cite

Rationale: Ovotesticular disorder of sex development (DSD), previously known as true hermaphroditism, is a disorder in which individuals have both testicular and ovarian tissues. Instances of tumors arising in the gonads of individuals with 46,XX ovotesticular DSD are uncommon. Patient concerns: We report a case of a 36-year-old phenotypical male with a chief complaint of an abdominal mass for 3 months. He reported normal erections and regular menses. Computerized tomography showed a large tumor measuring 15 × 10 cm in size, a uterus, and a cystic ovary. Diagnosis: 46, XX ovotesticular DSD with seminoma. Interventions: The patient was treated with neochemotherapy (etoposide and cisplatin), surgery, chemotherapy, and testosterone replacement. Outcomes: At the 13-month follow-up, the patient reported satisfactory erections, and no evidence of disease was found. Conclusion: Cases of 46,XX ovotesticular DSD with seminoma are uncommon. Our case reveals the importance of surgery combined with neochemotherapy, chemotherapy, and testosterone replacement in these patients to improve the prognosis.

show abstract

“… [6] Other causes of XX OT-DSD include mutations in NR5A1 , aberrant expression of SOX3 , duplication of SOX9 , and mutations in RSPO1 and WNT4 . [ 12 13 ]…”

Section: Discussionmentioning

confidence: 99%